| Literature DB >> 28274597 |
Claus F Vogelmeier1, Gerard J Criner2, Fernando J Martínez3, Antonio Anzueto4, Peter J Barnes5, Jean Bourbeau6, Bartolome R Celli7, Rongchang Chen8, Marc Decramer9, Leonardo M Fabbri10, Peter Frith11, David M G Halpin12, M Victorina López Varela13, Masaharu Nishimura14, Nicolás Roche15, Roberto Rodríguez-Roisin16, Don D Sin17, Dave Singh18, Robert Stockley19, Jørgen Vestbo18, Jadwiga A Wedzicha20, Alvar Agustí21.
Abstract
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: 1) the assessment of COPD has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 2) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 3) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; 4) nonpharmacologic therapies are comprehensively presented and; 5) the importance of comorbid conditions in managing COPD is reviewed.Entities:
Keywords: COPD; COPD management; COPD prevention; Chronic obstructive pulmonary disease; Diagnóstico de enfermedad pulmonar obstructiva crónica; EPOC; Evaluación; Prevención; diagnosis
Mesh:
Year: 2017 PMID: 28274597 DOI: 10.1016/j.arbres.2017.02.001
Source DB: PubMed Journal: Arch Bronconeumol ISSN: 0300-2896 Impact factor: 4.872